Page 37 - Breakthrough Device News Today

SALT LAKE CITY, UT / ACCESSWIRE / October 7, 2021 / IONIQ Sciences, Inc. ("IONIQ" or the "Company"), is developing a rapid and non-invasive Multi-Cancer Screen for early detection that has the potential

On September 15, 2021, the Centers for Medicare & Medicaid Services (“CMS” or the “Agency”) published a proposed rule, which (if finalized) would repeal the Agency’s Medicare Coverage...

Centers for Medicare & Medicaid Services CMS proposed rule would repeal Medicare Coverage of Innovative Technology & Definition of Reasonable and Necessary MCIT/R&N final rule; pathway to provide national Medicare coverage of medical devices designated Breakthrough Devices by Food and Drug Administration FDA

The U.S.

Hello friends and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - August 17, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has filed a supplement

An executive from the digital therapeutics specialist discusses the clinical trial landscape, and how clinical care can yield a number of important benefits.

If you injure your elbow, surgery can help. If you lose a leg, prostheses are available. But problems within the brain are more difficult to treat, and for stroke victims, rehabilitation is largely left to the body’s own repair mechanisms. BrainQ aims to change that with a device that stimulates the damaged part of the […]

MedRhythms Closes $25M Series B Funding to Advance Digital Therapeutics Platform MedRhythms announces the closing of a $25 million Series B financing round co-led by Morningside Ventures and Advantage Capital, with participation from existing investor Werth Family Investment Associates. It has raised a total of $34 million in gross proceeds from private financings since inception. The proceeds from the Series B financing will enable MedRhythms to expand its team and key corporate functions as t...

Press Release – Medical Technology Association of New Zealand The Insides System, a Kiwi-developed therapeutic intestinal contents (chyme) reinfusion system for intestinal failure (a severe condition where the body is unable to maintain adequate nutrition via the intestines) has won the James & Wells … The Insides™ System, a Kiwi-developed therapeutic intestinal contents (chyme) reinfusion system for intestinal failure (a severe condition where the body is unable to maintain adequate nut...